Guidance has been unveiled by the UK Medicines and Healthcare products Regulatory Agency outlining process changes for assessing established medicines that are aimed at shortening timeframes for assessment.
But while the British Generic Manufacturers Association has welcomed a faster assessment process, it has also underlined the need to clear the MHRA’s current backlog of approvals, urging more definite action on a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?